Found: 14
Select item for more details and to access through your institution.
Jinfukang inhibits clustering and invasion of circulating lung tumor cells by regulating the EGFR signaling pathway.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2023, v. 55, n. 11, p. 1851, doi. 10.3724/abbs.2023148
- By:
- Publication type:
- Article
Study on the Effect of Feiji Decoction for Soothing the Liver Combined with Psychotherapy on the Quality of Life for Primary Lung Cancer Patients.
- Published in:
- Chinese Journal of Lung Cancer, 2012, v. 15, n. 4, p. 213, doi. 10.3779/j.issn.1009-3419.2012.04.04
- By:
- Publication type:
- Article
A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1).
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-01063-4
- By:
- Publication type:
- Article
Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells.
- Published in:
- BMC Complementary & Alternative Medicine, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12906-019-2601-x
- By:
- Publication type:
- Article
Effects of Chinese Medicine as Adjunct Medication for Adjuvant Chemotherapy Treatments of Non-Small Cell Lung Cancer Patients.
- Published in:
- Scientific Reports, 2017, p. 46524, doi. 10.1038/srep46524
- By:
- Publication type:
- Article
Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials.
- Published in:
- Oncology Research & Treatment, 2019, v. 42, n. 7/8, p. 405, doi. 10.1159/000500204
- By:
- Publication type:
- Article
Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients.
- Published in:
- BMC Complementary & Alternative Medicine, 2012, v. 12, n. 1, p. 112, doi. 10.1186/1472-6882-12-112
- By:
- Publication type:
- Article
Identification of exosome protein panels as predictive biomarkers for non-small cell lung cancer.
- Published in:
- Biological Procedures Online, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s12575-023-00223-0
- By:
- Publication type:
- Article
Clinical and Biological Interpretation of Survival Curves of Cancer Patients, Exemplified With Stage IV Non-Small Cell Lung Cancers With Long Follow-up.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.837419
- By:
- Publication type:
- Article
"How Long Have I Got?" in Stage IV NSCLC Patients With at Least 3 Months Up to 10 Years Survival, Accuracy of Long-, Intermediate-, and Short-Term Survival Prediction Is Not Good Enough to Answer This Question.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.761042
- By:
- Publication type:
- Article
Investigating the immune mechanism of natural products in the treatment of lung cancer.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1289957
- By:
- Publication type:
- Article
In Metastatic Non-small cell Lung Cancer Platinum-Based Treated Patients, Herbal Treatment Improves the Quality of Life. A Prospective Randomized Controlled Clinical Trial.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00454
- By:
- Publication type:
- Article
Potential mechanisms underlying inhibition of xenograft lung cancer models by kaempferol: modulation of gut microbiota in activating immune cell function.
- Published in:
- Journal of Cancer, 2024, v. 15, n. 5, p. 1314, doi. 10.7150/jca.88038
- By:
- Publication type:
- Article
TRIM52 regulates the proliferation and invasiveness of lung cancer cells via the Wnt/β-catenin pathway.
- Published in:
- Oncology Reports, 2019, v. 41, n. 6, p. 3325
- By:
- Publication type:
- Article